Cancer-free survival of psoriasis patients treated with methotrexate and cyclosporine combination.
Combination of methotrexate and cyclosporine was used and reported to be effective for recalcitrant psoriasis patients. Also each agent is accused for development of malignancies. To evaluate the cancer-free survival of psoriasis patients who received methotrexate and cyclosporine treatment at the same time. Psoriasis patients who had been treated with combination of cyclosporine and methotrexate between March 2000 and April 2005 were questioned in 2011. A diagnosis of new cancer during follow-up period was asked and also each patient was evaluated by a questionnaire. Seventeen psoriasis patients were not treated due to a diagnosis of new cancer during the follow-up period. Also none of them complained of possible symptoms of skin or lymphoproliferative malignancies. The median follow-up time was 76 months. Psoriasis patients who had been treated with methotrexate and cyclosporine combination did not report a detected malignant disease.